3 articles
People with asthma and chronic obstructive pulmonary disease (COPD) who take the GLP-1 receptor agonist semaglutide appear to suffer significantly fewer acute respiratory attacks, according...
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing power of semaglutide — the active ingredient in Ozempic — without the...
Millions of Seniors Gain Access to Affordable Weight-Loss Medications In a historic shift in public health policy, Medicare has officially begun covering GLP-1 weight-loss drugs...